| Venous creatinine as a biomarker for loss of fat‐free mass and disease progression in patients with amyotrophic lateral sclerosis CJ Holdom, MR Janse van Mantgem, RPA van Eijk, SL Howe, ... European Journal of Neurology 28 (11), 3615-3625, 2021 | 14 | 2021 |
| Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey J Helleman, B Johnson, C Holdom, E Hobson, D Murray, FJ Steyn, ... Journal of neurology 269 (11), 6003-6013, 2022 | 12 | 2022 |
| Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis J Chang, TB Shaw, CJ Holdom, PA McCombe, RD Henderson, J Fripp, ... European Journal of Neurology 30 (1), 57-68, 2023 | 11 | 2023 |
| Use of hip-versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease CJ Holdom, JWJ van Unnik, RPA van Eijk, LH van den Berg, ... Journal of Neurology 270 (5), 2597-2605, 2023 | 5 | 2023 |
| Biofluid Biomarkers of Amyotrophic Lateral Sclerosis CJ Holdom, FJ Steyn, RD Henderson, PA McCombe, ML Rogers, ST Ngo Neurodegenerative diseases biomarkers: Towards translating research to …, 2022 | 4 | 2022 |
| Variation in resting metabolic rate affects identification of metabolic change in geographically distinct cohorts of patients with ALS CJ Holdom, MR Janse van Mantgem, J He, SL Howe, PA McCombe, ... Neurology 102 (5), e208117, 2024 | 1 | 2024 |
| Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with … SL Howe, CJ Holdom, PA McCombe, RD Henderson, JM Zigman, ST Ngo, ... European Journal of Neurology 31 (1), e16052, 2024 | 1 | 2024 |
| Variation in resting metabolic rate impacts identification of metabolic change in geographically distinct cohorts of amyotrophic lateral sclerosis patients CJ Holdom, MRJ van Mantgem, J He, SL Howe, PA McCombe, D Fan, ... METABOLIC ALTERATIONS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS, 91, 2023 | 1 | 2023 |
| Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis CJ Holdom, ST Ngo, PA McCombe, RD Henderson, FJ Steyn Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (1-2), 42-48, 2022 | | 2022 |
| Assessing the Metabolic Rate in Patients with Amyotrophic Lateral Sclerosis, Progressive Muscular Atrophy, and Primary Lateral Sclerosis MRJ van Mantgem, RPA van Eijk, CJ Holdom, MD den Berg METABOLIC ALTERATIONS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS, 139, 0 | | |
